Results 141 to 150 of about 53,568 (231)

Pathophysiological mechanisms of exercise intolerance in pulmonary tuberculosis patients

, 2021
Larisa Kiryukhina, Natalia Nefedova, Elena Kokorina, Е. Г. Соколович, Piotr Yablonskii, P.K. Yablonskii   +5 more
openalex   +1 more source

Implementation of guideline‐recommended medical therapy for patients with heart failure in Europe

ESC Heart Failure, Volume 12, Issue 2, Page 790-798, April 2025.
Abstract Physicians' adherence to guideline‐recommended heart failure (HF) treatment remains suboptimal, especially regarding the target doses. In particular, there is evidence that non‐cardiologists are less compliant with HF guideline recommendations. This is likely to have a detrimental impact on patients' survival, readmissions and quality of life.
Maurizio Volterrani, Petar Seferovic, Gianluigi Savarese, Ilaria Spoletini, Egidio Imbalzano, Antoni Bayes‐Genis, Ewa Jankowska, Michele Senni, Marco Metra, Ovidiu Chioncel, Andrew J. S. Coats, Giuseppe M. C. Rosano   +11 more
wiley   +1 more source

Out of breath and looking for options: Understanding pulmonary contributions to exercise intolerance in heart failure with preserved ejection fraction. [PDF]

J Physiol
Stickland MK.
europepmc   +1 more source

Exercise intolerance and training in heart failure with preserved ejection fraction

, 2015
Anisha A. Gupte, Dale J. Hamilton
openalex   +1 more source

A phenomap of TTR amyloidosis to aid diagnostic screening

ESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.
Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos, Theodoros Tsampras, George Lazaros, Konstantinos Tsioufis, Charalambos Vlachopoulos   +4 more
wiley   +1 more source

Altered autonomic cardiovascular function in adults with persisting post-concussive symptoms and exercise intolerance. [PDF]

Physiol Rep
Mercier LJ, McIntosh SJ, Burma JS, Batycky J, Joyce JM, Galarneau JM, Esser MJ, Schneider KJ, Smirl JD, Dukelow SP, Harris AD, Debert CT.   +11 more
europepmc   +1 more source

Supplementary Material for: Associated Pulmonary Hypertension Is an Independent Contributor to Exercise Intolerance in Chronic Fibrosing Interstitial Pneumonias

, 2018
David Yoo, Maurizio Zompatori, A Barrile, Giovanni Rossi, Daphne D’Amato, Gianluigi Sergiacomi, Paola Rogliani, Marco Mura   +7 more
openalex   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Oral octanoylcarnitine alleviates exercise intolerance in mouse models of long-chain fatty acid oxidation disorders. [PDF]

JCI Insight
Solo KJ, Zhang Y, Bharathi SS, Zhang BB, Richert AC, Schmidt AV, Van't Land C, D'Annibale O, Wood TC, Goetzman ES.   +9 more
europepmc   +1 more source

Peripheral arterial disease: an underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients [PDF]

, 2008
Olivier Castagna, Alain Boussuges, Eric S. Nussbaum, L. Marqueste, Jeanick Brisswalter   +4 more
openalex   +1 more source